Boult Wade Tennant
Bulletins » No time restriction on competence of the UPC

A recent decision of the Court of Appeal of the UPC has held that the competence of the UPC extends to acts of infringement committed before the entry into force of the UPCA.

Background and summary

The present appeal related to a dispute between ESKO-Graphics and XSYS. The European patent in question, EP 3 742 231 B1, was opted-out from the UPC and the opt-out was subsequently withdrawn. The question at issue was whether the UPC still has jurisdiction over any alleged infringement action that occurred in the time period prior to the effective date of the withdrawal.

In summary, the Court held that there was no time restriction on the competence of the UPC. In particular, the Court concluded that the UPC is competent to decide on alleged acts of infringement both before the entry into force of the UPCA and in the time period between the effective date of an opt-out and that of a withdrawal.

First, the Court considered that there was no provision in the UPCA for a time restriction on the competence of the UPC. Whilst acknowledging that the patent holder has a choice between initiating proceedings before the UPC or a national court during the transitional period, the Court held that this choice is limited to the choice of forum and does not provide reduced competence of the elected court, either in relation to the subject-matter or the time period over which the court is competent. Accordingly, the UPC is competent to decide on alleged acts of infringement before the entry into force of the UPCA. Moreover, the parallel competence of the national courts does not limit the exclusive competence of the UPC during the transitional period.

The Court then turned to consider the competence of the UPC when an opt-out is effectively withdrawn. The Court emphasised that when deciding to withdraw an opt-out, the patent holder is choosing to bring the patent under the exclusive jurisdiction of the UPC. In other words, if the opt-out is no longer in force, the patent is considered to have always been under the exclusive competence of the UPC, without any limitation. Accordingly, the UPC is competent to decide on any alleged acts of infringement that have occurred between the effective date of the opt-out and the withdrawal.

Key takeaways

  • The UPC is competent to decide on actions that occurred prior to the entry into force of the UPCA.
  • The UPC is competent to decide on actions that occurred in the time period between an opt-out and an effective withdrawal of the opt-out.
  • During the transitional period, the exclusive competence of the UPC exists in parallel with the competence of the national courts.

This case highlights that there is no time restriction on the competence of the UPC. Therefore, if an opt-out is withdrawn, the UPC can decide on any alleged acts of infringement irrespective of whether the acts were committed during the time period when the patent was opted-out.

Meet our UPC team.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications
Relevant sectors